BirtD.F.1986. Update on the effects of vitamins A, C, and E and selenium on carcinogenesis.Proc. Soc. Exper. Biol. and Med.183: 311–320.
2.
CabralJ.R.P., and NealG.E.1983. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats.Cancer Let.19: 125–132.
3.
ChipmanJ.K., and DaviesJ.E.1988. Reduction of 2-acetylaminofluorene-induced unscheduled DNA synthesis in human and rat hepatocytes by butylated hydroxytoluene.Mut. Res.207: 193–198.
4.
CohenL.A., PolanskyM., FuruyaK., ReddyM., BerkeB., and WeisburgerJ.H.1984. Inhibition of chemically induced mammary carcinogenesis in rats by short-term exposure to butylated hydroxytoluene (BHT): interrelationships among BHT concentration, carcinogen dose, and diet.JNCI72: 165–174.
5.
ChungF.L., WangM., CarmellaS.G., and HechtS.S.1986. Effects of butylated hydroxyanisole on the tumorigenicity and metabolism of N-nitrosodimethyl-amine and N-nitrosopyrrolidine in A/J mice.Cancer Res.46: 165–168.
6.
GranthamP.H., WeisburgerJ.H., and WeisburgerE.K.1973. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide.Fd. Cosmet. Toxicol.11: 209–217.
7.
ItoN., FukushimaS., and TsudaH.1985. Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants.CRC Critical Rev. in Toxicol.15: 109–150.
8.
KahlR.1984. Synthetic antioxidants: biochemical actions and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens.Toxicology33: 185–228.
9.
MaeuraY., WeisburgerJ.H., and WilliamsG.M.1984. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.Cancer Res.44: 1604–1610.
10.
MikuniT., TatsutaM., and KamachiM.1987. Scavanging effect of butylated hydroxytoluene on the production of free radicals by the reaction of hydrogen peroxide with N-ethyl-N'-nitrosoguanidine.JNCI79: 281–283.
11.
ReddyS.B., MaeuraY., and WeisburgerJ.H.1983. Effect of various levels of dietary butylated hydroxyanisole on methylazoxymethanol acetate-induced colon carcinogenesis in CF1 mice.JNCI71: 1299–1305.
12.
RogersA.E., and LongneckerM.P.1988. Dietary and nutritional influences on cancer: a review of epidemiologic and experimental data.Lab Invest.59: 729–759.
13.
SatoK., Kitahara, YinZ., WaragaiF., NishimuraK., Hatayama, EbinaT., YamazakiT., TsudaH., and ItoN.1984. Induction by butylated hydroxyanisole of specific molecular forms of glutathione s-transferase and UDP-glucuronyltransferase and inhibition of development of gamma-glutamyl transpeptidase-positive foci in rat liver.Carcinogenesis5: 473–477.
14.
ShambergerR.J., BaughmanF.F., KalchertS.L., WillisC.E., and HoffmanG.C.1973. Carcinogen-induced chromosomal breakage decreased by antioxidants.Proc. Nat. Acad. Sci. USA70: 1461–1463.
15.
UllandB.J., WeisburgerJ.H., YamamotoR., and WeisburgerE.K.1973. Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide in rats.Fd. Cosmet. Toxicol.11: 199–207.
16.
WattenbergL.W.1985. Chemoprevention of cancer.Cancer Res.45: 1–8.
17.
WattenbergL.W.1972. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin.JNCI48: 1425–1430.
18.
WeisburgerE.K., EvartsR.P., and WenkM.L.1977. Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane.Fd. Cosmet. Toxicol.15: 139–141.
19.
WilliamsG.M.1986. Epigenetic promoting effects of butylated hydroxyanisole.Fd. Chem. Toxicol.24: 1163–116.
20.
WilliamsG.M., MaeuraY., and WeisburgerJ.H.1983. Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytoluene.Cancer Let.19: 50–60.
21.
WilliamsG.M., TanakaT., and MaeuraY.1986. Dose-dependent inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.Carcinogenesis7: 1043–1050.
22.
WilliamsG.M., McQueenC.A., and TongC.1990. Butylated hydroxyanisole and butylated hydroxytoluene I.Genetic toxicology studies. Fd. Chem. Toxicol.28: 793–798.
23.
WilliamsG.M., TanakaT., MaruyamaH., MaeuraY., WeisburgerJ.H., and ZangE.1991. Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low level exposure to 2-acetylaminofluorene.Cancer Res.51: 6224–6230.
